Eric Topol

If he only would stick to the science of vaccines and what we understand about diseases and health outside of the food and the environment, then we'd be in good shape.

But this is the real problem.

It's the admixture of the things that he's

wants to do that allotable, taking on big food and big pharma, that sort of thing, with the unfortunate taking apart these public health agencies, which are critical to maintaining our health, especially when we're confronting potentially another pandemic.

It could happen, as you point out.

All right, well, this really is helpful.

It's always good to get your grounded, anchored,

well-informed, you know, perspective.

What have I missed, Caitlin?

Well, keep up the YLE.

When we met, you know, this is not just a couple weeks ago when we met, but let's say it was over a year ago when, and you said, I don't know what we're going to do when COVID, you know, simmers down.

It doesn't look like that's a problem now.

Well, keep up the good work.

Well, hello, this is Eric Topol from Ground Trust, and I am really delighted to welcome today Anna Greca.

Anna is the president of the American Society for Clinical Investigation this year, ASCI, a very prestigious organization.

But she's also at Mass General Brigham, a nephrologist, a cell biologist, a physician scientist, a core member of the Broad Institute and the executive leadership team, Harvard, MIT.

So she's got a lot.

We got a lot to talk about all these different things you do.

You must be pretty darn unique, Anna, because I don't know any cell biologists, nephrologists, physician scientists like you.

Yeah, well, I had the real pleasure to hear you speak at a November conference, the AI for Science Forum, which we'll link to your panel, where I was in a different panel, but you spoke about your extraordinary work in it.